• Explore /
  • Poster
  • / A randomized study of enzalutamide in patients with localized prostate cancer undergoing active surveillance (ENACT).

A randomized study of enzalutamide in patients with localized prostate cancer undergoing active surveillance (ENACT).

Abstract Poster

Authors

null

Neal D. Shore

Carolina Urologic Research Center, Myrtle Beach, SC

Neal D. Shore , Srinivas Vourganti , Jonathan L. Silberstein , Bruce A. Brown , Samuel Wilson , Courtney M.P. Hollowell , Matthew Cooperberg , Gwendoline Shang , Neil Eric Fleshner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT02799745

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS5097)

DOI

10.1200/JCO.2017.35.15_suppl.TPS5097

Abstract #

TPS5097

Poster Bd #

165b

Abstract Disclosures

Similar Posters

First Author: Wassim Abida

First Author: Benjamin H. Lowentritt

First Author: Andrew Leonard Laccetti

First Author: Shun Zhang